{
    "2021-08-23": [
        [
            {
                "time": "2021-08-23",
                "original_text": "复星医药上半年净利增44.77% 新冠疫苗复必泰贡献超5亿元收入",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新冠疫苗",
                        "复必泰",
                        "净利增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "市值蒸发3000亿后，孙飘扬将把恒瑞医药带向何处？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "孙飘扬",
                        "市值蒸发"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "华北制药断供集采被重罚，中标与落选 “双重困境”下药企路在何方？",
                "features": {
                    "keywords": [
                        "华北制药",
                        "断供",
                        "集采",
                        "重罚"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "A股大幅反弹北向资金加仓超18亿，持续加码高景气板块",
                "features": {
                    "keywords": [
                        "A股",
                        "北向资金",
                        "加仓",
                        "高景气板块"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "恒瑞医药半年报发出即跌停！走出创新转型阵痛期，恒瑞医药还有多远？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "半年报",
                        "跌停",
                        "创新转型"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "业绩远低预期市值缩水超3000亿 恒瑞医药延续下跌态势 盈利能力下降",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "业绩低预期",
                        "市值缩水",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-23",
                "original_text": "暴力反弹！创业板大涨2%，3000亿医药茅却创两年新低",
                "features": {
                    "keywords": [
                        "创业板",
                        "医药茅",
                        "暴力反弹",
                        "两年新低"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "创业板"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}